Belluscura Plc (BELL) ORD GBP0.01

Sell:0.75pBuy:0.75pNo change

Prices delayed by at least 15 minutes
Sell:0.75p
Buy:0.75p
Change:No change
Prices delayed by at least 15 minutes
Sell:0.75p
Buy:0.75p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The X-PLOR is a lightweight portable oxygen concentrator. The X-PLOR is also Bluetooth-compatible and can be connected to a mobile device through its newly developed Nomad Health App. DISCOV-R Portable Oxygen Concentrator. DISCOV-R weighs less than 6.5 lbs, producing more oxygen per pound than any other portable oxygen concentrator. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

Key people

Robert Rauker
Chief Executive Officer, Director
Robert Fary
Group Vice-President - Global Sales, Executive Director
Paul Tuson
Non-Executive Independent Chairman of the Board
David John Poutney
Non-Executive Director
Richard John Piper
Non-Executive Independent Director
Patrick Strollo
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    BELL
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    GB00BD3B8Z11
  • Market cap
    £3.01m
  • Employees
    35
  • Shares in issue
    401.31m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.